Article Name Medtech
Collaboration Set to Enhance Medical Imaging Through Gen AI & Software-Defined Architectures
21st November, 2023
Recent healthcare plan coverage of Intracept® system expands access to vertebrogenic pain treatment for tens of millions of patients
20th November, 2023
Medtronic plc a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension. With this approval, Medtronic will immediately begin commercialization.
20th November, 2023
ProPharma Group, the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and quality compliance services for the life sciences industry, has today launched a new Integrated Global MedTech Practice to provide end-to-end solutions for medical technology companies.
17th November, 2023
Addition of hemostatic patch complements Ethicon's comprehensive Biosurgery portfolio and ability to address critical unmet needs in controlling bleeding
16th November, 2023
The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.
15th November, 2023
New fund launched to implement 'Lab-to-Life' model to support neuroscience research
13th November, 2023
The LightSPAN research project has a two-pronged approach to prevent myopia in childhood and adolescence
13th November, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced collaborations with Ibex Medical Analytics and Amazon Web Services, enabling pathology laboratories to access Ibex’s AI-powered decision support tools to support clinicians in breast and prostate cancer diagnosis through the navify® Digital Pathology software platform.
10th November, 2023
Amidst the AI buzz, it's crucial to separate fact from fiction. GreenLight Guru survey of over 200 MedTech professionals delves into the present and future state of AI in the industry. Discover fascinating insights and trends as we analyze the surge, sentiments, and skepticism surrounding AI in MedTech.
07th November, 2023
Supported by US India SME Council for Expansion into US Markets
06th November, 2023
A historic milestone in the field of medicinal cannabis treatment
06th November, 2023
The core of a holistic health reform lies in the integration of emerging cutting-edge technologies into personalised care, emphasising interdisciplinary approaches. To fulfil the burgeoning healthcare requirement, Saudi Arabia is investing $500 billion to build an integrated megaproject region, NEOM, to create a human-centric care model through innovative systems, policies and infrastructure marvels. NEOM is forging to become a global benchmark for innovative technology, research, and education designing advanced treatments and comprehensive care. NEOM's holistic human-centred approach simplifies medical specialisations and gives individuals easy access to their medical profiles. Dr Mahmoud Alyamany, Head of NEOM Health, Wellbeing Sector elaborated on the futuristic health model during his recent visit to Singapore over ‘Discover NEOM’ global tour.
06th November, 2023
Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regions. Large players are very intent on tapping the large market potential in Asia. Many global companies have set up local presence in Asian countries and local production through original equipment manufacturer (OEM) partners in the countries to bring down the cost of their solutions, and more companies are expected to follow
06th November, 2023
New peripheral line draw solution delivers first and only compatibility with integrated catheters
06th November, 2023
Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembrolizumab treatment response
30th October, 2023
On Oct. 28th, Alltech, a high-end medical imaging equipment developer under the umbrella of Vital Group, held a press conference titled "Joy of Life, Dream of Innovation" at the 88th China International Medical Equipment Fair (CMEF), where it announced the latest product development strategy and Vital Group's inroad into high-end healthcare services.
30th October, 2023
Planning to open additional 7 labs by March 2024
30th October, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer